These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 16627812)

  • 21. Cardiac allograft vasculopathy after cardiac transplantation and hormone therapy: positive effects?
    Lange V; Renner A; Sagstetter M; Harms H; Elert O
    Transplantation; 2006 Jul; 82(2):234-40. PubMed ID: 16858287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiogenesis occurs within the intimal proliferation that characterizes transplant coronary artery vasculopathy.
    Atkinson C; Southwood M; Pitman R; Phillpotts C; Wallwork J; Goddard M
    J Heart Lung Transplant; 2005 May; 24(5):551-8. PubMed ID: 15896752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-stenosis after drug-eluting stents in cardiac allograft vasculopathy.
    Aqel RA; Wells BJ; Hage FG; Tallaj J; Benza R; Pamboukian S; Rayburn B; McGiffin D; Kirklin J; Bourge R
    J Heart Lung Transplant; 2008 Jun; 27(6):610-5. PubMed ID: 18503959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.
    Kittleson MM; Bead V; Fradley M; St John ME; Champion HC; Kasper EK; Russell SD; Wittstein IS; Hare JM
    J Heart Lung Transplant; 2007 May; 26(5):498-503. PubMed ID: 17449420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac allograft vasculopathy: current concepts and treatment.
    Waller J; Brook NR; Nicholson ML
    Transpl Int; 2003 Jun; 16(6):367-75. PubMed ID: 12756523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do cardiovascular risk factors influence cardiac allograft vasculopathy?
    Chamorro CI; Almenar L; Martínez-Dolz L; Sánchez-Lacuesta E; Martín-Pastor J; Ten-Morro F; Sánchez-Soriano RM; Agüero J; Ortiz V; Moro JA; Salvador A
    Transplant Proc; 2006 Oct; 38(8):2572-4. PubMed ID: 17098006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy.
    Haddad F; Perez M; Fleischmann D; Valantine H; Hunt SA
    J Heart Lung Transplant; 2006 Nov; 25(11):1367-70. PubMed ID: 17097503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanisms of transplant vasculopathy].
    Baron H; Plenz G; Deng MC
    Dtsch Med Wochenschr; 2004 Oct; 129(41):2193-7. PubMed ID: 15457400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common protective and diverse smooth muscle cell effects of AAV-mediated angiopoietin-1 and -2 expression in rat cardiac allograft vasculopathy.
    Nykänen AI; Pajusola K; Krebs R; Keränen MA; Raisky O; Koskinen PK; Alitalo K; Lemström KB
    Circ Res; 2006 Jun; 98(11):1373-80. PubMed ID: 16690881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left main coronary artery stenosis treatment with two paclitaxel-eluting stents in a patient with cardiac allograft vasculopathy.
    Martínez-Ríos MA; Méndez-Ortíz A; Gaspar J; Barragán-García R; Fernández-de-la-Reguera G; González-Quesada CJ
    Arch Cardiol Mex; 2008; 78(4):407-12. PubMed ID: 19205549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferation signal inhibitors and cardiac allograft vasculopathy.
    Raichlin E; Kushwaha SS
    Curr Opin Organ Transplant; 2008 Oct; 13(5):543-50. PubMed ID: 19060540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel roles of OX40 in the allograft response.
    Demirci G; Li XC
    Curr Opin Organ Transplant; 2008 Feb; 13(1):26-30. PubMed ID: 18660703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.
    Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A
    Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of proliferation signal inhibitors in the prevention and treatment of allograft vasculopathy in heart transplantation.
    Delgado JF; Manito N; Segovia J; Almenar L; Arizón JM; Campreciós M; Crespo-Leiro MG; Díaz B; González-Vílchez F; Mirabet S; Palomo J; Roig E; de la Torre JM
    Transplant Rev (Orlando); 2009 Apr; 23(2):69-79. PubMed ID: 19298938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production.
    Win TS; Rehakova S; Negus MC; Saeb-Parsy K; Goddard M; Conlon TM; Bolton EM; Bradley JA; Pettigrew GJ
    Circ Heart Fail; 2009 Jul; 2(4):361-9. PubMed ID: 19808360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-LFA-1 monotherapy prevents neointimal formation in a murine model of transplant intimal hyperplasia.
    Soleimani B; Wieczorek G; Katopodis A; Zenke G; George AJ; Hornick PI; Weitz-Schmidt G
    J Heart Lung Transplant; 2007 Jul; 26(7):724-31. PubMed ID: 17613404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AP-1 and STAT-1 decoy oligodeoxynucleotides attenuate transplant vasculopathy in rat cardiac allografts.
    Stadlbauer TH; Wagner AH; Hölschermann H; Fiedel S; Fingerhuth H; Tillmanns H; Bohle RM; Hecker M
    Cardiovasc Res; 2008 Sep; 79(4):698-705. PubMed ID: 18511434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low molecular weight fucan prevents transplant coronaropathy in rat cardiac allograft model.
    Alkhatib B; Freguin-Bouilland C; Lallemand F; Henry JP; Litzler PY; Marie JP; Richard V; Thuillez C; Plissonnier D
    Transpl Immunol; 2006 Jun; 16(1):14-9. PubMed ID: 16701171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of costimulatory pathway modulation on corneal allograft survival.
    Watson MP; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3417-22. PubMed ID: 16877411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.